TrialEndocrine2018
Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR.
Ernesto Sosa-Eroza et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papercites it
TrialEndocrine2018
Ernesto Sosa-Eroza et al.PubMed ↗Publisher ↗
No numbers read from the abstract.